EUS vs. MDCT in Pancreatic Malignancy

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

January 31, 2018

Study Completion Date

February 28, 2018

Conditions
Resectable Pancreatic Cancer
Trial Locations (5)

200638

Research Center in Gastroenterogy and Hepatology, Craiova

010825

University Military Hospital, Bucharest

020125

Gastroenterology Department, Clinical Hospital Colentina, Bucharest

Unknown

Fundeni Clinical Institute, Bucharest

Iuliu Hatieganu University of Medicine, Cluj-Napoca

Sponsors
All Listed Sponsors
collaborator

University of Medicine and Pharmacy Craiova

OTHER

collaborator

Iuliu Hatieganu University of Medicine and Pharmacy

OTHER

collaborator

Institutul Clinic Fundeni

OTHER

lead

Clinical Hospital Colentina

OTHER

NCT02115022 - EUS vs. MDCT in Pancreatic Malignancy | Biotech Hunter | Biotech Hunter